Graspeuntner, S.; Koethke, K.; Scholz, C.; Semmler, L.; Lupatsii, M.; Kirchhoff, L.; Herrmann, J.; Rox, K.; Wittstein, K.; Käding, N.;
et al. Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment. Antibiotics 2023, 12, 795.
https://doi.org/10.3390/antibiotics12050795
AMA Style
Graspeuntner S, Koethke K, Scholz C, Semmler L, Lupatsii M, Kirchhoff L, Herrmann J, Rox K, Wittstein K, Käding N,
et al. Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment. Antibiotics. 2023; 12(5):795.
https://doi.org/10.3390/antibiotics12050795
Chicago/Turabian Style
Graspeuntner, Simon, Katharina Koethke, Celeste Scholz, Lea Semmler, Mariia Lupatsii, Laura Kirchhoff, Jennifer Herrmann, Katharina Rox, Kathrin Wittstein, Nadja Käding,
and et al. 2023. "Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment" Antibiotics 12, no. 5: 795.
https://doi.org/10.3390/antibiotics12050795
APA Style
Graspeuntner, S., Koethke, K., Scholz, C., Semmler, L., Lupatsii, M., Kirchhoff, L., Herrmann, J., Rox, K., Wittstein, K., Käding, N., Hanker, L. C., Stadler, M., Brönstrup, M., Müller, R., Shima, K., & Rupp, J.
(2023). Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment. Antibiotics, 12(5), 795.
https://doi.org/10.3390/antibiotics12050795
